Clinical Trial Update: An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial updating tolerability and exploratory efficacy of zonisamide for dyskinesias in Parkinson's disease; study suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskinesias
• Parkinson Disease
• Parkinsonism

Drugs mentioned

• Zonisamide (zonisamide)

Snippet

Sponsor: The Cooper Health System | Conditions: Parkinson Disease, Parkinsonism | Phase 4 | Status: SUSPENDED